Literature DB >> 12068173

Malignant mullerian mixed tumor arising from ovarian serous carcinoma: a clinicopathologic and molecular study of two cases.

Alberto Gallardo1, Xavier Matias-Guiu, Helena Lagarda, Lluis Catasus, Elena Bussaglia, Esther Gras, Daniel Suarez, Jaime Prat.   

Abstract

The clinical, histologic, and molecular pathologic features of two cases of malignant mullerian mixed tumor (MMMT) arising from ovarian papillary serous carcinoma are presented. Identical p53 mutations were detected in the primary ovarian carcinoma and the subsequent MMMT in each case.

Entities:  

Mesh：

Year:  2002        PMID： 12068173     DOI： 10.1097/00004347-200207000-00010

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN： 0277-1691            Impact factor:   2.762


  9 in total

1.  Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship.

Authors:  Laura Ardighieri; Luigi Mori; Sara Conzadori; Mattia Bugatti; Marcella Falchetti; Carla Maria Donzelli; Antonella Ravaggi; Franco E Odicino; Fabio Facchetti
Journal:  Virchows Arch       Date:  2016-04-08       Impact factor: 4.064

Review 2.  Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

Authors:  Ie-Ming Shih; Robert J Kurman
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

3.  Metastatic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder.

Authors:  Soraya Puente; Ana Velasco; Pilar Gallel; Judit Pallares; Luis Perez-Ruiz; Susana Ros; Javier Maravall; Xavier Matias-Guiu
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

4.  Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study.

Authors:  Alexander Schipf; Doris Mayr; Thomas Kirchner; Joachim Diebold
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

Review 5.  Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Int J Gynecol Pathol       Date:  2008-04       Impact factor: 2.762

Review 6.  Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis.

Authors:  Robert J Kurman; Kala Visvanathan; Richard Roden; T C Wu; Ie-Ming Shih
Journal:  Am J Obstet Gynecol       Date:  2008-04       Impact factor: 8.661

7.  Serous Ovarian Carcinoma Recurring as Malignant Mixed Mullerian Tumor.

Authors:  Demir Hale; Demiroz Ahu Senem; Aydin Ovgu; Erenel Hakan; Ilvan Sennur; Calay Zerrin; Demirkiran Fuat
Journal:  Case Rep Obstet Gynecol       Date:  2015-12-02

8.  Peritoneal Carcinosarcoma and Ovarian Papillary Serous Carcinoma Are the Same Origin: Analysis of TP53 Mutation and Microsatellite Suggests a Monoclonal Origin.

Authors:  Chang Gok Woo; Dae Shik Suh; Joo Young Kim; Chang Ohk Sung; Jene Choi; Kyu-Rae Kim
Journal:  Korean J Pathol       Date:  2014-12-31

Review 9.  Cutaneous metastasis of carcinomatous component of ovarian carcinosarcoma: A case report and review of the literature.

Authors:  Jinhang Li; Chen Cao; Peng Liu; Zhifeng Yan; Deyin Xing; Aijun Liu
Journal:  Diagn Pathol       Date:  2022-10-05       Impact factor: 3.196
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.